CPC A61K 51/082 (2013.01) [A61K 9/51 (2013.01); A61K 47/6893 (2017.08); A61K 51/1027 (2013.01); C07D 255/02 (2013.01); C07D 257/02 (2013.01); C07K 7/06 (2013.01); C07K 7/64 (2013.01); C07K 16/30 (2013.01); G01N 33/5008 (2013.01); G01N 33/60 (2013.01); C07K 2319/00 (2013.01)] | 8 Claims |
1. A compound for molecular imaging or therapy comprising:
wherein A comprises a first peptide and a chelator;
wherein B comprises a second peptide;
wherein the chelator comprises a chelating core selected from the group consisting of NOTA, NETA, CB-TE2A, CB-TE1A1P, TETA, Pycu2A, DiAmSar, DOTA, DTPA, PCTA, and DFO; and
wherein the first and the second peptide are independently selected from the group consisting of NGR, LLP2A, BBN(7-14), Tyr(3)-octreotate, DAPTA, RGD c(cNGRc), c(RGDyK), and RAD.
|